What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?

PURPOSE OF REVIEW: We highlight the unique properties of the sodium-glucose cotransporter-2 (SGLT-2 inhibitors) which may lend favorably to their efficient integration in the background of other heart failure (HF) therapies. We also discuss the unique aspects of SGLT-2 inhibitor dosing, lack of titr...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Muhammad Shahzeb, Vaduganathan, Muthiah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Macrovascular Complications in Diabetes (VR Aroda and L-S Chang, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548057/
https://www.ncbi.nlm.nih.gov/pubmed/33040170
http://dx.doi.org/10.1007/s11892-020-01347-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548057/
https://www.ncbi.nlm.nih.gov/pubmed/33040170
http://dx.doi.org/10.1007/s11892-020-01347-3

Ejemplares similares